BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 9826622)

  • 1. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
    Roopnarine O; Leinwand LA
    Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.
    Cuda G; Fananapazir L; Epstein ND; Sellers JR
    J Muscle Res Cell Motil; 1997 Jun; 18(3):275-83. PubMed ID: 9172070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.
    Sata M; Ikebe M
    J Clin Invest; 1996 Dec; 98(12):2866-73. PubMed ID: 8981935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.
    Fujita H; Sugiura S; Momomura S; Omata M; Sugi H; Sutoh K
    J Clin Invest; 1997 Mar; 99(5):1010-5. PubMed ID: 9062359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
    Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
    J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.
    Rayment I; Holden HM; Sellers JR; Fananapazir L; Epstein ND
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3864-8. PubMed ID: 7731997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
    Eldin P; Le Cunff M; Mornet D; Leger JJ
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
    Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
    Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
    Keller DI; Coirault C; Rau T; Cheav T; Weyand M; Amann K; Lecarpentier Y; Richard P; Eschenhagen T; Carrier L
    J Mol Cell Cardiol; 2004 Mar; 36(3):355-62. PubMed ID: 15010274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Failure to Communicate: MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION.
    Kronert WA; Melkani GC; Melkani A; Bernstein SI
    J Biol Chem; 2015 Dec; 290(49):29270-80. PubMed ID: 26446785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac contractile proteins].
    Sugiura S; Sata M; Serizawa T
    Nihon Rinsho; 1993 May; 51(5):1146-50. PubMed ID: 8331781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin mutations in hypertrophic cardiomyopathy and functional implications.
    Vosberg HP
    Herz; 1994 Apr; 19(2):75-83. PubMed ID: 8194835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function studies of the myosin motor domain: importance of the 50-kDa cleft.
    Ruppel KM; Spudich JA
    Mol Biol Cell; 1996 Jul; 7(7):1123-36. PubMed ID: 8862525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.